Literature DB >> 9950286

Surface activity and concentration dependent intestinal permeability in the rat.

A Lindahl1, B Persson, A L Ungell, H Lennernäs.   

Abstract

PURPOSE: To investigate the relation between intestinal effective permeability (P(eff)) and surface activity of fluvastatin and verapamil.
METHODS: P(eff)-values were determined for fluvastatin, antipyrine and D-glucose following colon perfusions in the rat in situ. The perfusion solitions differed regarding concentrations of fluvastatin (0-2500 microM) and surface tension (58.9-43.7 mN/m). A cellulose derivative, ethyl-(hydroxyethyl) cellulose (EHEC), was added to lower the surface tension of one of the perfusion solutions. The surface tension of perfusion solutions containing R/S-verapamil (8-814 microM) and R/S-verapamil + chlorpromazine (814 microM + 10 mM) were related to the corresponding P(eff)-values from the literature.
RESULTS: The P(eff)of fluvastatin correlated inversely (r2 = 0.985, p < 0.05) with the surface tension of the perfusion solutions below the critical micelle concentration (CMC, 1 mM). Decreasing the surface tension with EHEC increased the P(eff) of fluvastatin by 36% (p < 0.001), but not to the extent anticipated from the correlation between the P(eff) and the surface tension. EHEC also increased the P(eff) of antipyrine by 49% (p < 0.01 ) but not for D-glucose. The P(eff) of R/S-verapamil correlated inversely with the surface tension (r2 = 0.980, p < 0.001).
CONCLUSIONS: The ability of fluvastatin to decrease the surface tension at the membrane surface can partly explain the concentration dependent colonic P(eff) of fluvastatin. This study shows that the surface activity of the drug molecule itself is an important physicochemical factor that should be taken into consideration when evaluating drug absorption studies performed in vitro or in situ.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950286     DOI: 10.1023/a:1018879014281

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

Review 1.  Solubilization of membranes by detergents.

Authors:  A Helenius; K Simons
Journal:  Biochim Biophys Acta       Date:  1975-03-25

2.  THE SURFACE ACTIVITY OF TRANQUILIZERS.

Authors:  P M SEEMAN; H S BIALY
Journal:  Biochem Pharmacol       Date:  1963-10       Impact factor: 5.858

3.  Effects of lovastatin on a human myeloma cell line: increased sensitivity of a multidrug-resistant subline that expresses the 170 kDa P-glycoprotein.

Authors:  M Holmberg; C Sandberg; P Nygren; R Larsson
Journal:  Anticancer Drugs       Date:  1994-10       Impact factor: 2.248

4.  Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers.

Authors:  T Lindmark; T Nikkilä; P Artursson
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

5.  Ionization and surface properties of verapamil and several verapamil analogues.

Authors:  G S Retzinger; L Cohen; S H Lau; F J Kézdy
Journal:  J Pharm Sci       Date:  1986-10       Impact factor: 3.534

6.  Enhancement of colonic drug absorption by the transcellular permeation route.

Authors:  M Tomita; M Hayashi; T Horie; T Ishizawa; S Awazu
Journal:  Pharm Res       Date:  1988-12       Impact factor: 4.200

7.  Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells.

Authors:  E K Anderberg; C Nyström; P Artursson
Journal:  J Pharm Sci       Date:  1992-09       Impact factor: 3.534

8.  Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability.

Authors:  S Drori; G D Eytan; Y G Assaraf
Journal:  Eur J Biochem       Date:  1995-03-15

9.  Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man.

Authors:  H Lennernäs; O Ahrenstedt; R Hällgren; L Knutson; M Ryde; L K Paalzow
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

10.  Reversal of multidrug resistance by surfactants.

Authors:  D M Woodcock; M E Linsenmeyer; G Chojnowski; A B Kriegler; V Nink; L K Webster; W H Sawyer
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

View more
  5 in total

1.  Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants.

Authors:  M Paulsson; K Edsman
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  No evidence for the involvement of the multidrug resistance-associated protein and/or the monocarboxylic acid transporter in the intestinal transport of fluvastatin in the rat.

Authors:  A Lindahl; S Frid; A L Ungell; H Lennernas
Journal:  AAPS PharmSci       Date:  2000

3.  HMG-CoA reductase inhibitors and P-glycoprotein modulation.

Authors:  K Bogman; A K Peyer; M Török; E Küsters; J Drewe
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

Review 4.  Clinical pharmacokinetics of atorvastatin.

Authors:  Hans Lennernäs
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  In Silico Prediction of Intestinal Permeability by Hierarchical Support Vector Regression.

Authors:  Ming-Han Lee; Giang Huong Ta; Ching-Feng Weng; Max K Leong
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.